Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Schellekens

Showing results (111-120 of 242) with videos related to

Pageof 25
Sort By:
European Addiction Research|August 30, 2022
Cognitive Functioning in Long-Term Benzodiazepine UsersShirley P G Zetsen, Arnt F A Schellekens, Erik P Paling, et al.
Bjpsych Open|March 20, 2025
Fluctuations in dispensed out-patient psychotropic medication prescriptions during the COVID-19 pandemic in The NetherlandsDamian A Visser, Daphne S Everaerd, Hannah Ellerbroek, et al.
Transplantation Proceedings|December 21, 2002
No long-term benefit of low-dose OKT3 induction therapy in non to moderately immunized renal allograft recipientsF J Bemelman, S Yong, K J Parlevliet, et al.
European Journal of Clinical Investigation|November 1, 1994
Hormone replacement therapy may reduce high serum homocysteine in postmenopausal womenM J van der Mooren, M G Wouters, H J Blom, et al.
European Addiction Research|July 14, 2020
Effects of Substance Misuse and Family History of Substance Use Disorder on Delay Discounting in Adolescents and Young Adults with Attention-Deficit/Hyperactivity DisorderMaria Paraskevopoulou, Daan van Rooij, Aart H Schene, et al.
European Journal of Clinical Pharmacology|June 17, 1998
Pharmacokinetics and cognitive effects of carbamazepine formulations with different dissolution ratesA P Aldenkamp, T Rentmeester, J Hulsman, et al.
Tijdschrift Voor Psychiatrie|August 3, 2019
[International consensus for the screening, diagnosis and treatment of adult patients with substance use disorder and ADHD]C L Crunelle, W van den Brink, A Schellekens, et al.
Drug and Alcohol Dependence|July 5, 2025
Facilitators and barriers for implementation of a decentralized hepatitis C care chain for people who use drugs in Dutch addiction careDaan W Von den Hoff, Hannah Ellerbroek, Joost P H Drenth, et al.
Journal of Psychoactive Drugs|June 17, 2026
Attitudes of Mental Healthcare Professionals Towards the Use of Psychedelics in the Treatment of Substance Use Disorders: A Systematic ReviewF van Dalen, S C Tap, S D Venema, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 13, 2010
Oral ileocolonic drug delivery by the colopulse-system: a bioavailability study in healthy volunteersR C A Schellekens, F Stellaard, G G Olsder, et al.
Pageof 25

Showing results (111-120 of 242) with videos related to

Sort By:
Pageof 25
European Addiction Research|August 30, 2022
Cognitive Functioning in Long-Term Benzodiazepine UsersShirley P G Zetsen, Arnt F A Schellekens, Erik P Paling, et al.
Bjpsych Open|March 20, 2025
Fluctuations in dispensed out-patient psychotropic medication prescriptions during the COVID-19 pandemic in The NetherlandsDamian A Visser, Daphne S Everaerd, Hannah Ellerbroek, et al.
Transplantation Proceedings|December 21, 2002
No long-term benefit of low-dose OKT3 induction therapy in non to moderately immunized renal allograft recipientsF J Bemelman, S Yong, K J Parlevliet, et al.
European Journal of Clinical Investigation|November 1, 1994
Hormone replacement therapy may reduce high serum homocysteine in postmenopausal womenM J van der Mooren, M G Wouters, H J Blom, et al.
European Addiction Research|July 14, 2020
Effects of Substance Misuse and Family History of Substance Use Disorder on Delay Discounting in Adolescents and Young Adults with Attention-Deficit/Hyperactivity DisorderMaria Paraskevopoulou, Daan van Rooij, Aart H Schene, et al.
European Journal of Clinical Pharmacology|June 17, 1998
Pharmacokinetics and cognitive effects of carbamazepine formulations with different dissolution ratesA P Aldenkamp, T Rentmeester, J Hulsman, et al.
Tijdschrift Voor Psychiatrie|August 3, 2019
[International consensus for the screening, diagnosis and treatment of adult patients with substance use disorder and ADHD]C L Crunelle, W van den Brink, A Schellekens, et al.
Drug and Alcohol Dependence|July 5, 2025
Facilitators and barriers for implementation of a decentralized hepatitis C care chain for people who use drugs in Dutch addiction careDaan W Von den Hoff, Hannah Ellerbroek, Joost P H Drenth, et al.
Journal of Psychoactive Drugs|June 17, 2026
Attitudes of Mental Healthcare Professionals Towards the Use of Psychedelics in the Treatment of Substance Use Disorders: A Systematic ReviewF van Dalen, S C Tap, S D Venema, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 13, 2010
Oral ileocolonic drug delivery by the colopulse-system: a bioavailability study in healthy volunteersR C A Schellekens, F Stellaard, G G Olsder, et al.
Pageof 25